Hospital Regional Universitario de Malaga Hospital General

Málaga, Málaga 29016

3 studies enrolling now · 8 studies all time

What they study most

Developmental and Epileptic Encephalopathy, Dravet Syndrome, Melanoma, Metastatic Melanoma, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Metastatic or Unresectable Cutaneous Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Unresectable Melanoma

Studies at this site

• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
• Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. — Recruiting now
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) — Enrolling by invitation
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) — Running, not enrolling
• Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors — Stopped early
• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed